The global medical imaging market was valued at USD 41.64 billion in 2024 and is projected to increase to USD 43.72 billion in 2025, reaching around USD 67.87 billion by 2034. This growth reflects a CAGR of 4.99% between 2025 and 2034.
This growth is driven by rising chronic disease incidence, an aging population, and technological innovations—notably AI integration, portable/point-of-care systems, 3D/4D imaging, and hybrid modalities. North America remains the largest regional market, but Asia-Pacific and Europe are fast-catching leaders, buoyed by improving healthcare infrastructure, favorable policies, and increasing investments.
MRI currently holds a dominant share technologically, while CT is the fastest-growing segment. Hospitals are the primary end-users, though diagnostic centers are rapidly expanding. Among applications, orthopedic imaging leads today, with oncology expected to be the fastest-growing.
Key players include GE Healthcare, Siemens Healthineers, Philips, Canon, Fujifilm, Carestream, Hologic, and emerging AI-focused firms. The market’s future will be shaped by continued digital transformation—AI-enabled analytics, radiogenomics, cloud-based PACS, and multimodal integration offering precision diagnostics.
Download this Free Sample Now and Get the Complete Report and Insights of this Market Easily @ https://www.towardshealthcare.com/download-sample/5649
2024 (Base Year):
The global market stood at USD 41.64 billion. This year marks the foundation of the forecast period, with North America holding the largest regional share (37%).
2025 (Next Year):
The market expanded to USD 43.72 billion, reflecting an early growth momentum supported by strong hospital adoption and technological advances.
Forecast Horizon (2025–2034):
The market is projected to advance at a CAGR of 4.99%, sustaining steady year-on-year growth.
2034 (Long-Term Projection):
By the end of the forecast period, the global market is expected to reach USD 67.87 billion, adding more than USD 24 billion in incremental opportunity over 10 years.
| Year | Market Size (USD Billion) | Growth Observation |
|---|---|---|
| 2024 | 41.64 | Base year, market leadership by MRI & hospitals |
| 2025 | 43.72 | Early growth, +2.08 billion from 2024 |
| 2030 | 55.6 (estimated) | Mid-term benchmark, steady CAGR progress |
| 2034 | 67.87 | End of forecast, +26.23 billion from 2024 |
● Generative AI for Reporting & Communication
Radiologists increasingly use generative AI (e.g. ChatGPT-like models) to draft reports and handle administrative tasks, freeing them up for complex image interpretation.
● AI Adoption Per Gaps & Risks
Overreliance on AI may degrade clinician skills—one study found colonoscopy detection rates dropped when doctors operated without AI assistance.
● Widespread Clinical Use with Human Oversight
Over 340 AI imaging tools have FDA approval, aiding in detecting strokes, tumors, and breast cancer. Two-thirds of US radiology departments already employ AI, while maintaining human oversight.
● Regulatory Scrutiny & Transparency
Regulatory authorities (e.g., FDA, MHRA, EMA) are tightening oversight in 2025, demanding greater model explainability and rigorous validation of AI tools.
● Adaptive Scan Protocols with AI
Imaging protocols are becoming more personalized—tailored based on patient history, risk profiles, and even genetic information for diseases like cancer, neurology, and cardiology.
● Radiomics & Predictive Modeling
Quantitative imaging data (radiomics) is driving precision medicine, enabling tumors and diseases to be characterized and predicted more accurately.
● Handheld & Mobile Devices
Handheld ultrasound and portable X-ray devices are becoming more advanced and affordable—especially useful for rural and emergency settings.
● Teleradiology Advancements
Cloud-based platforms enable image sharing and remote interpretation. Specialists can access studies from anywhere, improving care in underserved areas.
● Photon-Counting CT & Digital SPECT
Photon-counting CT offers higher resolution and lower radiation; digital SPECT improves nuclear imaging accuracy.
● 3D, 4D, AR/VR, Fusion Imaging
3D/4D imaging is revolutionizing surgical planning, fetal monitoring, and joint/neurosurgical precision. AR overlays imaging data during surgery; fusion imaging (e.g., PET/CT or MRI/US) delivers combined anatomical-functional insights.
● AI-Powered Cloud Platforms
AI-enhanced cloud imaging improves real-time diagnostics, collaboration, and integration with EHRs.
● Evolving from PACS to Intelligent IT Systems
Traditional PACS are transitioning into advanced, AI-integrated, cloud-based platforms offering analytics and teleimaging.
● In-Silico Clinical Trials
Simulation of imaging outcomes via digital patient models is being increasingly accepted by regulatory bodies, accelerating R&D.
● Theranostics (Theranostic Imaging + Treatment)
Combining imaging (e.g., PET/SPECT) with targeted therapy—especially for oncology, neurology, and cardiology—is gaining traction for precision intervention.
● Quantum & Next-Gen Imaging
Quantum tech is entering imaging—from quantum sensors mapping magnetic fields without radiation to image-enhancing technologies using quantum light—especially relevant to future diagnostics.
● Private Preventive Imaging
Full-body MRIs are increasingly used for proactive diagnostics (e.g., Prenuvo, Prenuvo study detected cancers not typically screened).
● Public-Private Integration
In the UK, the NHS deployed AI (like the “Edith” platform) for large-scale breast screening. Private startups (e.g., Neko, Scan.com) are complementing public systems.
● Budget Constraints & ROI-focused Procurement
Economic pressures are moving investments toward cost-effective diagnostics (e.g. coronary CTA), while delaying large capital purchases.
● Security & Data Privacy
As imaging goes cloud-based, cybersecurity becomes paramount to protect patient data.
● Eco-conscious & Sustainable Imaging
Trends include low-radiation imaging, energy-efficient devices, and equipment recycling practices.
● Early Disease Detection: Escalating NCD burden pushes demand for early, accurate imaging.
● Aging Demographics: Elderly populations amplify need for musculoskeletal, cardiovascular, and neurological imaging.
● Technological Innovation: Transformative breakthroughs—AI, photon-counting CT, portable devices—enhance image quality and workflow.
● Healthcare Infrastructure Expansion: Investments in hospitals and diagnostic centers increase equipment procurement.
● Policy & Reimbursement Support: Government incentives, favorable reimbursement (seen in North America/Europe) accelerate adoption.
● Data Quality & Standardization: Incomplete or low-quality imaging data may impair diagnostics.
● High Costs & Budget Constraints: Cutting-edge modalities like MRIs and CTs require significant capital.
● Regulatory & Ethical Challenges: AI deployments face liability, privacy, and validation roadblocks.
● Digital Infrastructure Gaps: Cloud/PACS migration demands robust IT capabilities, which may lag in emerging markets.
● 3D/4D Imaging Expansion: Enhanced anatomical visualization and functional insights.
● AI-Augmented Workflows: Boost diagnostic accuracy, reduce radiologist burden, enable predictive analytics (radiogenomics).
● Portable & Remote Solutions: Enabling point-of-care access in rural/low-resource areas.
● Asia-Pacific Growth: Rapid infrastructure rollout, favorable demographics, and government funding open emerging markets.
● Interoperable, Cloud-based Platforms: Seamless data sharing, real-time collaboration, and cost-efficient storage.
● AI systems can identify subtle patterns and variations in medical images that might be too small or complex for the human eye to detect.
● This capability helps radiologists and clinicians catch diseases at earlier stages, such as detecting small tumors, microfractures, or early signs of degenerative disorders.
● AI and machine learning (ML) automate repetitive, time-consuming tasks like image segmentation, lesion detection, and measurement.
● This reduces the burden on healthcare professionals and allows them to focus more on decision-making and patient care.
● Medical imaging produces vast datasets (e.g., MRI, CT scans, X-rays).
● AI algorithms can rapidly process these datasets, ensuring quicker turnaround times while maintaining consistency and precision in results.
● AI doesn’t just analyze imaging data in isolation. It can combine imaging information with patient history, lab results, and even genetic information.
● This integration enables precision medicine, where treatment and diagnosis are tailored to the unique profile of each patient.
● Human interpretation of images may vary between experts. AI delivers standardized, reproducible results, reducing diagnostic errors caused by fatigue, oversight, or subjective interpretation.
● This improves patient safety and ensures uniform quality of care across healthcare centers.
● By automating reporting and flagging urgent cases, AI optimizes radiology workflows.
● It helps prioritize patients who need immediate attention, reducing delays in diagnosis and treatment.
● Faster detection and greater accuracy mean patients receive timely interventions.
● This leads to improved prognosis, reduced complications, and overall better healthcare outcomes.
Market Leadership:
● North America captured 37% of the global market in 2024, making it the leading region.
● The region’s dominance is fueled by robust healthcare infrastructure, strong adoption of advanced imaging tools, and government support.
Key Growth Drivers:
● Presence of leading global players such as GE Healthcare and Sectra Medical.
● High adoption of technological innovations in imaging modalities.
● Substantial investments and partnerships between academia and industry to advance imaging research.
● Government efforts to increase access to medical imaging through funding and streamlined regulations.
U.S. Market Trends:
● 40 million MRI scans performed annually, showcasing very high utilization.
● 129 million Americans live with at least one chronic disorder, driving imaging demand for early and frequent diagnosis.
● In March 2024, ARPA-H and CDRH partnered to improve access to affordable, high-quality imaging data.
Canada Market Trends:
● Government-backed initiatives to standardize and track imaging usage.
● The Canadian Medical Imaging Inventory (CMII), managed by the Canada Drug Agency, documents:
● Supply and distribution of imaging equipment.
● Technical operations and usage.
● Clinical and research practices.
● This provides clear visibility into national imaging resources and ensures better allocation.
Growth Outlook:
● Expected to be the fastest-growing region during 2025–2034.
● Factors include rapid expansion of healthcare infrastructure, rising investments, and growing geriatric population.
Key Growth Drivers:
● Increasing prevalence of chronic disorders.
● Government screening and early-diagnosis initiatives.
● Funding support for advanced imaging device adoption in hospitals.
● Growing private sector and public-private collaborations.
China Market Trends:
● Government action plan for dementia by 2030, spanning prevention, early diagnosis, treatment, rehabilitation, and care.
Widespread cognitive functional screenings for the elderly to detect dementia risk early.
● Focus on integrating imaging into national dementia strategy, boosting demand for advanced scanners.
India Market Trends:
● 4,500 MRI machines installed across healthcare organizations.
● The PLI Scheme for Medical Devices promotes domestic manufacturing of imaging equipment.
● Investment commitment of ₹3,420 crore (2020–2028) to strengthen radiology, imaging, oncology, and implant technologies.
● This positions India as both a large consumer market and an emerging manufacturing hub for medical imaging.
Growth Outlook:
● Europe is a highly promising region due to increasing adoption of imaging tools, healthcare sector growth, and supportive government policies.
● Government and private institutions organize seminars, conferences, and workshops to educate people on the importance of early disease diagnosis.
Key Growth Drivers:
● Universal healthcare systems encourage access to imaging.
● Growing healthcare expenditure on modernization of equipment.
● Favorable regulatory policies for adoption of innovative imaging devices.
Germany Market Trends:
● 32.5 MRI machines per million people – one of the highest densities worldwide, ranking fifth among universal healthcare nations
● Home to 37,000+ medical technology companies, creating a dense industrial ecosystem for imaging.
● Major companies like Siemens Healthineers and SternMed dominate equipment supply and exports.
UK Market Trends:
● Government investments to reduce waiting lists:
● £1.5 billion for new surgical hubs and scanners.
● £70 million for radiotherapy machines.
● Context: Over 7.6 million people were waiting for appointments, scans, or surgeries in August 2024, highlighting urgent imaging demand.
● Radiography: Uses X-rays or gamma rays to visualize internal structures in a static 2D image—commonly used for diagnosing fractures, chest conditions, and dental imaging.
● Fluoroscopy: A dynamic imaging technique using continuous X-ray to produce real-time moving images—useful in guiding procedures like catheter insertion and monitoring contrast passage through the GI tract.
● Mammography: A specialized low-dose X-ray technique to detect breast cancer—often considered a subset of radiography.
● Leverages acoustic (sound) waves to create real-time moving images. Commonly used in obstetrics (e.g., fetal imaging), cardiology (echocardiography), and general diagnostics. It’s radiation-free and safe in sensitive cases like pregnancy.
● Produces cross-sectional “slice” images by rotating an X-ray source and detectors around the patient; reconstructed by computer algorithms. Particularly useful in detailed bone, lung, and brain imaging, or when MRI is contraindicated (e.g., metallic implants).
Subtypes (as per your segmentation):
● High-end slice CT
● Mid-range slice CT
● Low-end slice CT
● Cone Bone CT
● Utilizes strong magnetic fields and radio waves to generate high-contrast images of soft tissues without ionizing radiation—ideal for brain, spinal cord, muscles, tendons, and breast tissues.
● Closed System: Traditional design where the patient lies inside a tunnel-like magnet.
● Open System: Designed to reduce claustrophobia, featuring more space and open architecture.
● Focuses on physiological and metabolic insights using radioactive tracers—not just anatomical images.
● SPECT (Single Photon Emission Computed Tomography): Uses gamma rays from injected isotopes to create 3D functional images; useful when combined with CT (SPECT-CT) for anatomical context.
● PET (Positron Emission Tomography): Leverages positron-emitting tracers to visualize metabolic processes (e.g., FDG for tumor imaging); often merged with CT or MRI in hybrid devices (PET-CT/PET-MRI).
From your segmentation list, typical application areas include:
Cardiology
Oncology
Neurology
Orthopedics
Gastroenterology
Gynecology
Others
● Hospitals: Major users for comprehensive imaging diagnostics.
● Diagnostic Imaging Centers & Others: Recognized industry segments, though not elaborated in Wikipedia.
You listed a wide geographic segmentation—covering:
North America (US, Canada)
Asia Pacific (China, Japan, India, South Korea, Thailand)
Europe (Germany, UK, France, Italy, Spain, Sweden, Denmark, Norway)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (MEA) (South Africa, UAE, Saudi Arabia, Kuwait)
1. GE HealthCare
● Overview: A global leader in medical technology and diagnostics.
● Product: Revolution CT, Signa MRI, Vivid Ultrasound systems.
● Highlight: Strong focus on AI-driven imaging solutions and cloud integration.
● Strength: Extensive global footprint and continuous R&D investment.
2. Siemens Healthineers
● Overview: A pioneer in advanced imaging and diagnostic solutions.
● Product: SOMATOM CT scanners, MAGNETOM MRI, Acuson Ultrasound.
● Highlight: Known for cutting-edge AI-powered imaging and precision medicine tools.
● Strength: Strong hospital partnerships and innovative product pipeline.
3. Philips Healthcare
● Overview: A multinational company focused on health technology and patient care.
● Product: Ingenia MRI, Incisive CT, EPIQ Ultrasound.
● Highlight: Emphasis on sustainable imaging and connected care platforms.
● Strength: Strong AI integration with a focus on patient experience.
4. Canon Medical Systems
● Overview: A global provider of imaging solutions under Canon Inc.
● Product: Aquilion CT, Vantage MRI, Aplio Ultrasound.
● Highlight: Known for imaging accuracy and radiation dose reduction technologies.
● Strength: Strong after-sales service and reliability in imaging equipment.
5. Fujifilm Holdings Corporation
● Overview: A diversified Japanese company excelling in imaging and healthcare.
● Product: Synapse PACS, Aspire mammography systems, CT and MRI solutions.
● Highlight: Leadership in PACS and enterprise imaging IT solutions.
● Strength: Strong imaging software ecosystem and global adaptability.
6. Hologic, Inc.
● Overview: A U.S.-based leader in women’s health and diagnostic imaging.
● Product: 3D Mammography (Genius exam), bone densitometry systems.
● Highlight: Specialization in breast and skeletal health imaging.
● Strength: Dominant market position in mammography and women’s health imaging.
7. Shimadzu Corporation
● Overview: A Japanese company with a broad healthcare and scientific portfolio.
● Product: Trinias angiography, MobileDaRt X-ray, Sonialvision radiography systems.
● Highlight: Strong in digital X-ray and interventional imaging systems.
● Strength: Reliability and affordability for emerging markets.
Date: May 2025
Region: European Market
Details:
● Launched the VeriSight Pro 3D ICE catheter, designed for structural heart and electrophysiology procedures.
● Provides an end-to-end imaging solution for clinicians performing complex cardiac interventions such as:
● Tricuspid and mitral valve repair and replacement
● Atrial septal defect closure
● Left atrial appendage occlusion
Impact: Enhances real-time intracardiac visualization, improves procedural precision, and helps reduce complications in minimally invasive cardiac procedures.
Date: April 2025
Region: India
Details:
● Introduced Spark.ai, an AI-driven radiology workflow platform.
● Features include:
Automation of routine documentation tasks
● Reduction in manual workload for radiologists
● Faster report turnaround times
● Streamlined case management
Impact: Helps radiologists concentrate more on clinical decision-making, ensures quicker diagnosis delivery, and addresses the growing demand for imaging services in India.
Date: May 2025
Region: Global
Details:
● Philips partnered with NVIDIA to integrate its AI computing platform into MRI systems.
● Focus areas of the collaboration:
● Improving MRI image quality with advanced AI-driven reconstruction
● Accelerating scan times, reducing patient discomfort and throughput challenges
● Enhancing workflow efficiency and diagnostic accuracy
Impact: Marks a significant advancement in the integration of AI into imaging hardware, setting a standard for faster, more precise MR imaging solutions.
Date: February 2025
Region: Global
Details:
● Collaboration to combine:
● Stratasys’ RadioMatrix 3D printing materials
● Digital Anatomy technology
● Siemens Healthineers’ advanced CT algorithms
● Joint research focuses on producing realistic, high-quality anatomical phantoms for CT imaging.
Key outcomes:
● Phantoms enable development and testing of new CT scan algorithms
● Support enhanced diagnostic precision in clinical practice
● Reduce reliance on cadavers or animal models for imaging trials
Impact: Establishes a breakthrough in 3D printing and imaging research, expanding possibilities for personalized medical imaging and training.
1. What is the size of the global medical imaging market in 2024?
The global medical imaging market size is estimated at USD 41.64 billion in 2024.
2. How fast is the medical imaging market growing?
The market is projected to expand at a CAGR of 4.99% from 2025 to 2034.
3. What will be the market size of medical imaging by 2034?
It is expected to reach around USD 67.87 billion by 2034.
4. Which imaging technology dominates the market?
X-ray and ultrasound technologies hold the largest share due to wide clinical adoption, while MRI and CT are growing rapidly with advanced applications.
5. Which regions are leading in medical imaging adoption?
North America leads due to advanced healthcare infrastructure and R&D.
Asia-Pacific is the fastest-growing region, driven by higher investments and increasing patient population.
Get instant access to this premium research with immediate delivery @ https://www.towardshealthcare.com/price/5649
Access our exclusive, data-rich dashboard dedicated to the diagnostics sector – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
Become a valued research partner with us – https://www.towardshealthcare.com/schedule-meeting
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
Web: https://www.towardshealthcare.com
Connect us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest
The global healthcare contact center as a service market was valued at USD 5.86 billion in 2024, grew to USD… Read More
The global medical membrane market was valued at USD 4.26 billion in 2024 and is expected to grow to USD… Read More
The global surgical sutures market, also known as the medical stitches industry, is on a steady growth trajectory. Surgical sutures… Read More
The global pharma contract research organization (CRO) services market is experiencing significant growth, projected to expand from USD 36.66 billion… Read More
The global Pharma Contract Research Organization (CRO) services market is experiencing significant growth, projected to reach USD 87.03 billion by 2034,… Read More
The global Pharma Contract Research Organization (CRO) services market, valued at USD 36.66 billion in 2025, is projected to reach… Read More